The APP R&R: Read and Relax series was developed by the SGO APP Committee and is meant to be an informal opportunity for APPs and other allied health professionals working directly in gyn onc patient care to get together virtually to connect, discuss a piece of literature (journal article, book, etc.) each quarter, and learn from one another in a casual, relaxed environment. 

Please join us virtually for the next APP R&R: Read and Relax session!  We will be discussing the SORAYA data and the recent FDA approval of Mirvetuximab Soravtansine for patients with platinum resistant ovarian cancer who have high folate receptor alpha expression in their tumor.  Please review the attached publication prior to attending.  We look forward to seeing you!

Note: this series is designed for those currently working directly in patient care settings. 

SORAYA_Mirv.pdf